Published in CNS Drugs on January 01, 2002
Paroxetine-induced increase in activity of locus coeruleus neurons in adolescent rats: implication of a countertherapeutic effect of an antidepressant. Neuropsychopharmacology (2010) 1.53
Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol (2006) 1.34
Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved. Front Pharmacol (2013) 0.84
SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents. J Can Acad Child Adolesc Psychiatry (2011) 0.83
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder. Prim Care Companion CNS Disord (2015) 0.75
Hypotension following cardiac surgery associated with paroxetine and mirtazapine withdrawal. J Pediatr Pharmacol Ther (2008) 0.75
Depressive and negative symptoms in schizophrenia: different effects on clinical features. Compr Psychiatry (2005) 0.90
Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients. J Clin Psychiatry (2004) 0.89
Clinical picture of obsessive-compulsive disorder with poor insight: a regression model. Psychiatry Res (2005) 0.85
Major depression in patients with borderline personality disorder: a clinical investigation. Can J Psychiatry (2005) 0.80
Serotonin transporter gene: a new polymorphism may affect response to antidepressant treatments in major depressive disorder. Mol Diagn Ther (2014) 0.80
No effect of serotoninergic gene variants on response to interpersonal counseling and antidepressants in major depression. Psychiatry Investig (2013) 0.75
[Interpersonal psychotherapy: a model of intervention for borderline personality disorder]. Riv Psichiatr (2014) 0.75